| 2025-05-05 | -1.4 % |
- Biogen's stock (NASDAQ: BIIB) declined by 1.4% following a target price reduction by Canaccord Genuity Group, which lowered its forecast from $265 to $220, despite the company maintaining a buy rating.
The drop in stock price is attributed to analysts lowering their price targets and ratings for Biogen, alongside the company's recent earnings miss, where its earnings per share fell short of expectations.
- Biogen (NASDAQ:BIIB) stock dropped by 1.4% following a downgraded price target by HC Wainwright, which lowered it to $187.00, indicating bearish sentiment among analysts.
- Biogen Inc. (NASDAQ: BIIB) experienced a 1.4% decline in stock value following its quarterly earnings report that missed consensus estimates, causing investor concern despite some analysts raising future earnings predictions.
The decline in Biogen's stock was primarily due to the company reporting earnings of $3.02 per share, which fell short of the expected $3.26, raising concerns among investors about its current performance.
- Biogen Inc. (NASDAQ:BIIB) stock fell by 1.4% due to multiple price target reductions from various research firms and a recent quarterly earnings report that showed missed earnings expectations despite revenue growth.
- Biogen (BIIB) stock declined by 1.4% after HC Wainwright lowered its target price from $241.00 to $187.00, amidst a series of downgrades from several analysts highlighting concerns over the company’s earnings performance.
|
| 2025-05-02 | +2.15 % |
|
| 2025-05-01 | -0.12 % |
|
| 2025-04-30 | +0.76 % |
|
| 2025-04-29 | +0.88 % |
|
| 2025-04-25 | -0.56 % |
|
| 2025-04-23 | -0.61 % |
|
| 2025-04-21 | -1.79 % |
|
| 2025-04-17 | +2.88 % |
|
| 2025-04-10 | -5.9 % |
|
| 2025-04-08 | -4.31 % |
|
| 2025-04-07 | -3.08 % |
|
| 2025-04-01 | -3.52 % |
|
| 2025-03-27 | -1.47 % |
|
| 2025-03-25 | -1.72 % |
|
| 2025-03-24 | +0.5 % |
|
| 2025-03-21 | -0.34 % |
|
| 2025-03-18 | -0.31 % |
|
| 2025-03-17 | +2.94 % |
|
| 2025-03-11 | -4.68 % |
|
| 2025-02-25 | +1.55 % |
|
| 2025-02-18 | -0.55 % |
|
| 2025-02-14 | -0.81 % |
|
| 2025-02-13 | +3.76 % |
|
| 2025-02-12 | -4.28 % |
- Biogen (BIIB) stock fell by 4.28% following mixed analyst ratings, including a downgrade from BMO Capital Markets that reduced its price target from $230 to $164, contributing to a generally negative sentiment among investors.
- Biogen (BIIB) stock declined by 4.28% amid a broader market downturn driven by a hotter-than-expected inflation reading for January, which led investors to reassess expectations for Federal Reserve interest rate cuts in 2025.
- Biogen (BIIB) stock fell by 4.28% after the company exceeded fourth-quarter earnings and sales expectations but provided a disappointing earnings outlook for 2025.
- Biogen (BIIB) stock fell 4.28% following a forecast for 2025 profits that fell short of Wall Street expectations, primarily due to the impact of a strong dollar and increased competition for its multiple sclerosis treatments.
- The article primarily discusses Biogen's (BIIB) stock performance, noting a decline of 4.28% without detailing the specific reasons for this drop; however, context from other financial news suggests that such movements could be due to various macroeconomic factors, earnings forecasts, or changes in analyst ratings that might negatively impact investor sentiment.
- Biogen (NASDAQ: BIIB) stock fell 4.28% primarily due to multiple analysts including TD Cowen and Needham & Company downgrading their ratings and cutting the price targets for the stock, reflecting a less optimistic outlook on the company's performance.
- Biogen (BIIB) stock fell by 4.28% due to investor concerns about competition and the relative strength of alternative investment opportunities, particularly highlighted by the potential upside of BioCardia compared to Biogen in the context of other small-cap medical companies.
|
| 2025-02-11 | -2.21 % |
|
| 2025-02-07 | -0.72 % |
|
| 2025-02-06 | -2.17 % |
|
| 2025-02-05 | +2.13 % |
|
| 2025-02-04 | +0.11 % |
|
| 2025-01-31 | -1.57 % |
|
| 2025-01-28 | -2.2 % |
|
| 2025-01-27 | +1.75 % |
|
| 2025-01-22 | +1.26 % |
|
| 2025-01-16 | +0.16 % |
|
| 2025-01-15 | -1.44 % |
|
| 2025-01-14 | -4.74 % |
|
| 2025-01-13 | +0.91 % |
|
| 2025-01-10 | -1.28 % |
|
| 2025-01-06 | +0.7 % |
|
| 2025-01-02 | -1.91 % |
|
| 2024-12-30 | -0.74 % |
|
| 2024-12-24 | -0.24 % |
|
| 2024-12-23 | +1.99 % |
|
| 2024-12-19 | +0.41 % |
|
| 2024-12-17 | +0.1 % |
|
| 2024-12-09 | -0.84 % |
|
| 2024-12-04 | +0.04 % |
|
| 2024-11-27 | +1.36 % |
|
| 2024-11-26 | -0.64 % |
|
| 2024-11-25 | +0.51 % |
|
| 2024-11-20 | +0.37 % |
|
| 2024-11-18 | -1.28 % |
|
| 2024-11-13 | -1.48 % |
|
| 2024-11-11 | -0.58 % |
|
| 2024-11-07 | -0.28 % |
|
| 2024-11-06 | -1.43 % |
|
